CN101534803A - 给予含有药物的薄膜产品的方法 - Google Patents

给予含有药物的薄膜产品的方法 Download PDF

Info

Publication number
CN101534803A
CN101534803A CNA2007800409505A CN200780040950A CN101534803A CN 101534803 A CN101534803 A CN 101534803A CN A2007800409505 A CNA2007800409505 A CN A2007800409505A CN 200780040950 A CN200780040950 A CN 200780040950A CN 101534803 A CN101534803 A CN 101534803A
Authority
CN
China
Prior art keywords
film
thin film
poly
combination
ethylene oxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007800409505A
Other languages
English (en)
Chinese (zh)
Inventor
G·L·迈尔斯
R·C·福兹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aquestive Therapeutics Inc
Original Assignee
MonoSol Rx LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MonoSol Rx LLC filed Critical MonoSol Rx LLC
Publication of CN101534803A publication Critical patent/CN101534803A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CNA2007800409505A 2006-09-26 2007-09-25 给予含有药物的薄膜产品的方法 Pending CN101534803A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/526,996 2006-09-26
US11/526,996 US20080050422A1 (en) 2001-10-12 2006-09-26 Method of administering a film product containing a drug

Publications (1)

Publication Number Publication Date
CN101534803A true CN101534803A (zh) 2009-09-16

Family

ID=39166452

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007800409505A Pending CN101534803A (zh) 2006-09-26 2007-09-25 给予含有药物的薄膜产品的方法

Country Status (7)

Country Link
US (1) US20080050422A1 (https=)
EP (1) EP2079457A2 (https=)
JP (1) JP2010504993A (https=)
CN (1) CN101534803A (https=)
AU (1) AU2007300197A1 (https=)
CA (1) CA2664669A1 (https=)
WO (1) WO2008039737A2 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102440979A (zh) * 2010-09-30 2012-05-09 迪特克(济源)绿色生物科技有限公司 一种纤维素衍生物复合膜及其制备方法
CN102048711B (zh) * 2009-11-11 2013-06-05 河北奥星集团药业有限公司 一种格拉司琼膜制剂及其制备方法
CN111655242A (zh) * 2018-01-26 2020-09-11 Lts勒曼治疗系统股份公司 多层口服薄膜

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100753959B1 (ko) * 2006-01-12 2007-08-31 에이펫(주) 기판 건조장치를 이용한 기판 건조방법
JP4916894B2 (ja) * 2007-01-11 2012-04-18 株式会社ツキオカ フィルム状製剤及びフィルム状製剤の製造方法
US8323695B2 (en) 2007-08-13 2012-12-04 Mcneil-Ppc, Inc. Method for stabilizing phenylephrine
US8623401B2 (en) * 2008-03-27 2014-01-07 Fenwafe Inc. Wafer formulation
US20110159058A1 (en) * 2008-08-25 2011-06-30 Kyukyu Pharmaceutical Co., Ltd. Film preparation containing loperamide hydrochloride
PT2952191T (pt) 2009-06-12 2018-11-30 Sunovion Pharmaceuticals Inc Apomorfina sublingual
JP2012532133A (ja) * 2009-06-30 2012-12-13 ダウ グローバル テクノロジーズ エルエルシー 日焼け防止剤含有可溶性フィルム
DK3254676T3 (en) 2009-10-30 2019-03-11 Ix Biopharma Ltd QUICK-SOLVING SOLID DOSAGE FORM
US12186426B2 (en) 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
CA2784587A1 (en) 2009-12-28 2011-07-28 Monosol Rx, Llc Orally administrable film dosage forms containing ondansetron
US20120308635A1 (en) * 2009-12-30 2012-12-06 Novartis Ag Melt extruded thin strips containing coated pharmaceutical
JP6050564B2 (ja) * 2010-03-11 2016-12-21 テイカ製薬株式会社 フィルム状製剤
NZ612686A (en) 2010-12-16 2015-11-27 Cynapsus Therapeutics Inc Sublingual films
US11129799B2 (en) * 2011-04-12 2021-09-28 Aquestive Therapeutics, Inc. Dual lane coating
ES2699806T3 (es) * 2012-04-18 2019-02-12 SpecGx LLC Composiciones farmacéuticas, disuasivas del abuso, de liberación inmediata
PT3164117T (pt) 2014-07-03 2023-12-12 SpecGx LLC Formulações de libertação imediata de dissuasão de abuso compreendendo polissacáridos não celulósicos
US20160220480A1 (en) * 2015-02-03 2016-08-04 Intelgenx Corp. Oral dosage film exhibiting enhanced mucosal penetration
JP7211706B2 (ja) 2015-04-21 2023-01-24 サノヴィオン ファーマシュティカルズ インコーポレーテッド 口腔粘膜へのアポモルフィンの投与によるパーキンソン病の治療方法
JP2018197216A (ja) * 2017-05-24 2018-12-13 株式会社プラスアルファー フィルムシート状栄養剤
JP6842998B2 (ja) * 2017-05-30 2021-03-17 日清ファルマ株式会社 コエンザイムｑ１０フィルム製剤
US11648197B2 (en) * 2018-06-28 2023-05-16 Arx, Llc Dispensing method for producing dissolvable unit dose film constructs
US20210267934A1 (en) * 2018-07-15 2021-09-02 Rapid Dose Therapeutics Corp. Cannabinoid oral dispersible film strip
WO2020068510A1 (en) 2018-09-25 2020-04-02 SpecGx LLC Abuse deterrent immediate release capsule dosage forms
EP3895691A1 (en) * 2020-04-15 2021-10-20 LTS Lohmann Therapie-Systeme AG Ulipristal acetate otf
EP3895692A1 (en) * 2020-04-15 2021-10-20 LTS Lohmann Therapie-Systeme AG Oral thin film with smooth fused film

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855326A (en) * 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture
AU679937B2 (en) * 1992-11-18 1997-07-17 Johnson & Johnson Consumer Products, Inc. Extrudable compositions for topical or transdermal drug delivery
US7666337B2 (en) * 2002-04-11 2010-02-23 Monosol Rx, Llc Polyethylene oxide-based films and drug delivery systems made therefrom
ATE398465T1 (de) * 2001-11-16 2008-07-15 Givaudan Sa Essbare folie
MXPA02011337A (es) * 2001-11-16 2003-05-26 Nat Starch Chem Invest Peliculas que contienen almidon.
WO2006031209A1 (en) * 2003-05-28 2006-03-23 Monosolrx Llc Polyethylene oxide-based films and drug delivery systems made therefrom
EP1504765B1 (en) * 2002-05-16 2015-07-22 Kyukyu Pharmaceutical Co., Ltd. Quickly soluble film preparations
GB0217382D0 (en) * 2002-07-26 2002-09-04 Pfizer Ltd Process for making orally consumable dosage forms
EP2335921A1 (en) * 2004-09-30 2011-06-22 MonoSolRX, LLC Multi-layer films

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102048711B (zh) * 2009-11-11 2013-06-05 河北奥星集团药业有限公司 一种格拉司琼膜制剂及其制备方法
CN102440979A (zh) * 2010-09-30 2012-05-09 迪特克(济源)绿色生物科技有限公司 一种纤维素衍生物复合膜及其制备方法
CN111655242A (zh) * 2018-01-26 2020-09-11 Lts勒曼治疗系统股份公司 多层口服薄膜

Also Published As

Publication number Publication date
AU2007300197A1 (en) 2008-04-03
US20080050422A1 (en) 2008-02-28
WO2008039737A3 (en) 2008-05-22
EP2079457A2 (en) 2009-07-22
CA2664669A1 (en) 2008-04-03
WO2008039737A2 (en) 2008-04-03
JP2010504993A (ja) 2010-02-18

Similar Documents

Publication Publication Date Title
CN101534803A (zh) 给予含有药物的薄膜产品的方法
CN101668519A (zh) 聚合物基薄膜以及由其制备的药物递送系统
JP6109865B2 (ja) 非自己凝集性で均一な混成を示す薄いフィルム、およびそれから作製した薬物送達システム
JP6035369B2 (ja) 自己凝集しない均一な異種性を有する薄膜、その生成方法、およびそれから製造した薬物送達系
CN102670568A (zh) 基于聚氧乙烯的薄膜及由其制造的药物传递系统
JP4739452B2 (ja) 発泡を減じる風味付与剤を含む喫食可能な水溶性フィルム
JP2009518405A (ja) 活性物質の送達のための局所フィルム組成物
CN101889990A (zh) 奥丹西隆膜组合物
CN101316579A (zh) 含有抗粘组合物的用于快速溶解剂型的均匀膜
CN101616660A (zh) 高剂量膜组合物及其制备方法
EP2167034A1 (en) Film shreds and delivery systems incorporating same
CN103002885A (zh) 用于递送活性成分的膜组合物
CN105229401B (zh) 通过控制干燥失重使湿薄膜干燥的方法
JP2010509905A6 (ja) 発泡を減じる風味付与剤を含む喫食可能な水溶性フィルム
US20070154527A1 (en) Topical film compositions for delivery of actives
CN101346135A (zh) 用于活性剂递送的已调节pH的膜
CN105209026A (zh) 用于利扎曲坦的薄膜和药物递送系统

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20090916